Why gummy supplements are growing in Europe
12 February 2026 · 5 min read
Gummy supplements have shifted from a children's-only niche into a mainstream adult format across Europe. The dynamics behind that shift sit on three tracks — format preference, retailer-side organisation and DTC channel economics — and each one has implications for how brands plan their gummy SKUs.
Format preference Format preference is consumer-driven, not brand-driven. Adult consumers increasingly choose chewable formats over tablets and capsules for the "daily-routine" use case. Brands launching wellness or beauty ranges treat at least one gummy SKU as part of the lineup, not a separate experiment.
Retailer-side organisation Retail buyers are organising the supplement shelf around use cases (immune, beauty, sleep) rather than format. A range that ships only capsules now reads as one-format inside a multi-format category — a competitive risk worth a brief.
DTC route economics DTC supplement brands are increasingly led by gummy heroes: format meets ritual, ritual meets retention. The capsule companions still sit alongside, but the marketing-led SKU is more often the gummy.
This is not a quantitative claim about how much each track contributes. The takeaway is qualitative: brands building an EU range in 2026 should plan a gummy hero SKU and a companion architecture, not the reverse.
Ingredients mentioned
- Vitamin CVitamin C is a water-soluble vitamin and antioxidant essential to human collagen synthesis, immune function, and energy metabolism. In gummy formats it is one of the most commonly used actives — well-tolerated, stable in the gummy matrix when properly formed, and supported by 14 EU-authorised health claims under Regulation 432/2012.
- Vitamin D3Vitamin D3 (cholecalciferol) is a fat-soluble vitamin essential for calcium absorption, bone health, muscle function, and immune support. It is one of the most commonly requested actives in private-label gummy ranges — particularly for bone, immunity, and daily-multivitamin positionings — with seven EU-authorised health claims under Regulation 432/2012.